safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy

drake m., athanasiou s., herholdt c., kaper m., saleem t., huang m., ...Daha Fazla

Annual Meeting of the International-Continence-Society, 6 - 08 Ekim 2015

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Dokuz Eylül Üniversitesi Adresli: Evet